Zeposia 0.92 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB26FXCS6
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,621
Award facts
- Contract value 100% obligated
- $4,620.94 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on October 23, 2025, by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, covers the supply of Zeposia 0.92 mg capsules (30-count) with a ceiling value of $4,620.94 and a firm fixed-price structure. The award is non-set-aside and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. This delivery order is a child contract issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
The broader IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a diverse range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The company's contract portfolio demonstrates extensive experience fulfilling federal medical supply requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices. The DLA Troop Support Medical Supply Chain utilizes this prime vendor arrangement to efficiently procure medications and related healthcare products for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. Zeposia is a prescription medication used in the treatment of multiple sclerosis and ulcerative colitis, representing the type of specialized pharmaceutical commodity delivered through this strategic contracting vehicle.
Quick answers
Who was awarded contract SPE2DB26FXCS6?
SPE2DB26FXCS6 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DB26FXCS6 worth?
The government has obligated $4,621 on SPE2DB26FXCS6.
Is contract SPE2DB26FXCS6 an order under another contract?
Yes. SPE2DB26FXCS6 is a delivery order under SPE2DB24D2003, an indefinite delivery contract.
Was contract SPE2DB26FXCS6 competed?
The extent of competition for SPE2DB26FXCS6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award